Search term: archive
2008 / 07
Your search is limited to one month, search the whole site for archive.
PHARMAC documents that matched your search:
30 July 2008 Proposal to list DP-Anastrozole and amend the Special Authority criteria applying to Aromatase Inhibitors for hormone receptor positive breast cancer Proposal summary PHARMAC and Douglas Pharmaceuticals Ltd have reached a provisional agreement for funding of Douglas’ brand…
25 July 2008 Proposal to Amend the General Rules regarding Substitution and Alteration to Quantity Dispensed PHARMAC is seeking public feedback on a proposal to amend the restrictions and other general rules that apply to subsidies on community pharmaceuticals (the…
PHARMAC is pleased to announce the approval of funding for a new antipsychotic treatment, aripiprazole (Abilify), from 1 August 2008.
PHARMAC’s Board has approved the funding of the Keppra brand of the antiepilepsy agent levetiracetam for selected patients via a special access process, from 1 August 2008.
Accounts Payable Coordinator - closes 15 July 2008
(1 page, 139 KB)
Accounts Payable Coordinator Position Description (ad to follow)
(2 pages, 117 KB)